Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04336969 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D - 4T Study

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Results posted: Oct 8, 2026 Show 8 more changesShow less
    • Sponsor refiled this as active, not recruiting (was completed)
    • Study completion date: Jul 1, 2025 to Jul 1, 2030
    • Eligibility criteria shortened, about 21 words
    • Secondary endpoints: 11 to 12
    • Primary endpoint revised
    • Study site revised
    • Publications: details revised at 6 of 6 entries
    • Study arms: 1 to 2
  2. Trial status: Active, Not Recruiting to Completed
    • Study completion date changed from estimate of Dec 30, 2026 to Jul 1, 2025
    • Study description expanded, about 79 words
    • Publications: 4 to 6
    v14
  3. Re-verified, no change to tracked fieldsv13
  4. Primary completion date: May 31, 2025 to Jul 1, 2025v12
  5. Trial status: Enrolling by Invitation to Active, Not Recruitingv11 Show 4 more changesShow less
    • Enrollment target: estimated 500 to confirmed 316
    • Publications: details revised at 1 of 4 entries
    • Eligibility criteria shortened, about 3 words
    • Study description expanded, about 5 words
Show 9 earlier versionsHide 9 earlier versions
  1. Primary completion date: Oct 31, 2024 to May 31, 2025
    • Study completion date: Dec 30, 2025 to Dec 30, 2026
    v10
  2. Primary completion date: Jul 31, 2025 to Oct 31, 2024
    • Study completion date: Jul 31, 2025 to Dec 30, 2025
    v9
  3. Primary completion date: Oct 31, 2024 to Jul 31, 2025
    • Study completion date: Dec 30, 2025 to Jul 31, 2025
    v8
  4. Primary completion date: Apr 30, 2022 to Oct 31, 2024v7 Show 4 more changesShow less
    • Study completion date: Apr 30, 2025 to Dec 30, 2025
    • Eligibility criteria expanded, about 51 words
    • Study description expanded, about 69 words
    • Study site revised
  5. Secondary endpoints: 10 to 11v6
  6. Primary completion date: Dec 15, 2022 to Apr 30, 2022
    • Study completion date: Dec 15, 2023 to Apr 30, 2025
    v5
  7. Primary endpoints: 5 to 1
    • Secondary endpoints: 6 to 10
    v4
  8. Primary completion date: Apr 30, 2022 to Dec 15, 2022
    • Study completion date: Apr 30, 2025 to Dec 15, 2023
    • Start date: Jun 22, 2020 to Jun 18, 2020
    v3
  9. Trial status: Not Yet Recruiting to Enrolling by Invitationv2 Show 5 more changesShow less
    • Primary endpoints: 6 to 5
    • Start date changed from estimate of May 1, 2020 to Jun 22, 2020
    • Eligibility criteria revised
    • Secondary endpoints revised (6)
    • Study description expanded, about 1 word
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stanford University
634 trials monitored
See 47 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Type 1 Diabetes
886 trials monitored
See 40 trials at risk
The 4T program encompasses: Teamwork, Targets, Technology, and Tight Range. These methods will help patients better manage their condition of Type 1 Diabetes with improved patient-reported outcomes.
Trial Details
NCT Number NCT04336969
Lead Sponsor Stanford University
Collaborators: National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)		 Type1diabetes
Enrollment 316 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov